Latest return on equity
Barinthus Biotherapeutics Return on equity
Barinthus Biotherapeutics (BRNS) return on equity with its verified observation…
Direct answer
Barinthus Biotherapeutics's return on equity is -52.38%.
The verified market snapshot reports -52.38%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 1, 2026.
Get free Barinthus Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -52.38%
Explore related company data
View Barinthus Biotherapeutics's market capitalizationView Barinthus Biotherapeutics's price-to-book ratioView Barinthus Biotherapeutics's 52-week price rangeView Barinthus Biotherapeutics's profit marginView Barinthus Biotherapeutics's debt-to-equity ratioView all Barinthus Biotherapeutics key metricsReturn to Barinthus Biotherapeutics profile